3/19
01:20 pm
abeo
Abeona Therapeutics: Maintaining 'Buy' On ZEVASKYN Launch Potential For RDEB [Seeking Alpha]
Low
Report
Abeona Therapeutics: Maintaining 'Buy' On ZEVASKYN Launch Potential For RDEB [Seeking Alpha]
3/19
08:22 am
abeo
Abeona Therapeutics (ABEO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Abeona Therapeutics (ABEO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
3/18
06:44 pm
abeo
Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point [Seeking Alpha]
Low
Report
Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point [Seeking Alpha]
3/17
06:06 pm
abeo
Abeona Therapeutics (ABEO) was given a new $17.00 price target by Stifel Nicolaus.
Medium
Report
Abeona Therapeutics (ABEO) was given a new $17.00 price target by Stifel Nicolaus.
3/17
03:26 pm
abeo
Abeona Therapeutics Inc (ABEO) Q4 2025 Earnings Call Highlights: Strong Demand for Zivasskin ... [Yahoo! Finance]
Low
Report
Abeona Therapeutics Inc (ABEO) Q4 2025 Earnings Call Highlights: Strong Demand for Zivasskin ... [Yahoo! Finance]
3/17
10:01 am
abeo
Abeona (ABEO) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Abeona (ABEO) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/17
08:13 am
abeo
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates [Yahoo! Finance]
Low
Report
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates [Yahoo! Finance]
3/17
07:35 am
abeo
Abeona Therapeutics GAAP EPS of $1.01 misses by $0.17, revenue of $5.82M beats by $0.6M [Seeking Alpha]
Medium
Report
Abeona Therapeutics GAAP EPS of $1.01 misses by $0.17, revenue of $5.82M beats by $0.6M [Seeking Alpha]
3/17
07:30 am
abeo
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
Low
Report
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
3/10
11:34 am
abeo
Abeona Therapeutics Says ZEVASKYN Launch Is Back on Track, Eyes Profitability in 2026 [Yahoo! Finance]
Low
Report
Abeona Therapeutics Says ZEVASKYN Launch Is Back on Track, Eyes Profitability in 2026 [Yahoo! Finance]
3/10
08:03 am
abeo
Abeona Therapeutics (ABEO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Abeona Therapeutics (ABEO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
3/9
04:05 pm
abeo
Abeona Therapeutics (ABEO) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc..
Low
Report
Abeona Therapeutics (ABEO) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc..
3/9
07:30 am
abeo
Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
Medium
Report
Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
3/3
08:10 pm
abeo
????????????????????: ??????????2035????245????????????????????????????????18.24%??????(CAGR)???????? [CNET News]
Low
Report
????????????????????: ??????????2035????245????????????????????????????????18.24%??????(CAGR)???????? [CNET News]
3/3
07:30 am
abeo
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
Low
Report
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
2/9
10:04 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/31
09:22 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
12/31
07:30 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)